This protocol is judged by an institutional overview board, an independent group that opinions any clinical trials involving people. If a analyze consists of a Schedule I drug, when the board approves the protocol as moral, the scientists really have to apply for an investigational new drug (IND) variety from the FDA.With all the doses packaged an